Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03170401 · ClinicalTrials.gov registry record · Phase 3
Supplemental Enteral Protein in Critical Illness
A Phase 3 study of Critical Illness and Trauma, sponsored by University of Washington.
- Completed
- Registry status
- Phase 3
- Development phase
- 500
- Enrollment target
- 1
- Study location
NCT03170401 is a Phase 3 study of Critical Illness and Trauma that has completed, run by University of Washington. The registered enrollment target is 500 participants, below the 3,133-participant average among 91 other Critical Illness trials with a reported enrollment target (84% lower). The trial reports 1 study location across 1 state.
The verdict
NCT03170401, a Phase 3 study of Critical Illness and Trauma, has completed, sponsored by University of Washington.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 500 participants
- Enrollment target
- 1
- Study location
Study Summary
The aim of this study is too determine the effect of enteral protein supplementation on biochemical measures of inflammation and protein metabolism in critically ill surgical patients. The investigators will also collect data on important clinical outcomes, including infectious complications, duration of mechanical ventilation and other measures of recovery from critical illness. Hypothesis: That early supplemental protein will increase serum concentrations of transthyretin at three weeks after the onset of illness or injury. Secondarily, the investigators will test whether supplementation, reduces infectious complications and increases ventilator-free days.
Conditions Studied
Interventions
- DIETARY_SUPPLEMENT Protein supplementation
- OTHER Standard enteral nutrition
Study Locations (1)
Washington
- Harborview Medical Center - Seattle
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 500 participants |
| Start Date | 2016-11 |
| Est. Completion | 2022-12 |
| Phase | Phase 3 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03170401
The ClinicalTrials.gov registry entry for NCT03170401 describes a study currently listed as completed, categorized as Phase 3. The registered enrollment target is 500 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 3,133-participant average among 91 other Critical Illness trials with a reported enrollment target (84% lower). The listed sponsor is University of Washington, which has 1,048 total studies on file at ClinicalTrials.gov.
The record links to 3 conditions, with Critical Illness appearing as the primary indexed condition, and to 2 interventions - of which Protein supplementation is the first listed.
NCT03170401 reports 1 study location spanning 1 distinct geographic area - top geographies include Washington.
Frequently Asked Questions
What is clinical trial NCT03170401 about?
NCT03170401 is a clinical study titled "Supplemental Enteral Protein in Critical Illness". The aim of this study is too determine the effect of enteral protein supplementation on biochemical measures of inflammation and protein metabolism in critically ill surgical patients. The investigators will also collect data on important clinical outcomes, including infectious complications, durati...
What is the current status of trial NCT03170401?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 500 participants. The study started on 2016-11. Estimated completion is 2022-12.
What conditions does trial NCT03170401 study?
This clinical trial studies the following conditions: Critical Illness, Trauma, Nutrition Disorder.
What interventions are being tested in trial NCT03170401?
The interventions under investigation include: Protein supplementation (DIETARY_SUPPLEMENT), Standard enteral nutrition (OTHER).
Who is sponsoring clinical trial NCT03170401?
This trial is sponsored by University of Washington, which has 1,048 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03170401 being conducted?
This trial has 1 study location across Washington. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Critical Illness
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Goal-Directed Sedation in Mechanically Ventilated Infants and Children
RECRUITING · Phase 3
-
Strategy to Avoid Excessive Oxygen for Critically Ill Trauma Patients
ACTIVE NOT RECRUITING · Phase 3
-
Strategy to Avoid Excessive Oxygen in Major Burn Patients
ACTIVE NOT RECRUITING · Phase 3
-
Efficacy and Mechanisms of GLN Dipeptide in the SICU
COMPLETED · Phase 3
-
Oral Care to Reduce Mouth and Throat Infections in Critically Ill Patients
COMPLETED · Phase 3
-
Preoperative Fasting vs. Not Fasting in Critically Ill Patients
RECRUITING · NA
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.